Recruiting now—Ages 0 Years to 49 Years

Observational Study on Skeletal Ewing's Sarcoma

Sponsor: Italian Sarcoma Group · NCT04845893 on ClinicalTrials.gov ↗

Bring this to your care team →

Conditions studied

Ewing Sarcoma of Bone

What it tests

Treatment of Ewings Sarcoma of bone according clinical practice (includes drugs, surgery, radiotherapy or any other received treatments)other

Where it's running19 sites

19 international sites

Istituto Clinico Humanitas
Rozzano, MI, Italy 20089
Recruiting now
- Alexia Bertuzzi, MD(contact)+390282244540 [email protected]
- Alexia Bertuzzi, MD(principal investigator)
Centro di Riferimento Oncologico - Unit of Medical Oncology
Aviano, Pordenone, Italy 33081
Recruiting now
- Maurizio Mascarin, MD(contact)+390434659 [email protected]
- Maurizio Mascarin, MD(principal investigator)
I.R.C.C. - Unit of Medical Oncology
Candiolo, Torino, Italy 10060
Recruiting now
- Sandra Aliberti, MD(contact)+390119933250 [email protected]
- Sandra Aliberti, MD(sub investigator)
Azienda ospedaliero universitaria consorziale policlinico - bari
Bari, Italy 70124
Recruiting now
- Francesco De Leonardis, MD(contact)00390805592 [email protected]
- Francesco De Leonardis, MD(principal investigator)
A.O. Universitaria Policlinico S. Orsola Malpighi di Bologna
Bologna, Italy 40138
Recruiting now
- Arcangelo Prete, MD(contact)+390516363 [email protected]
- Arcangelo Prete, MD(principal investigator)
Istituto ortopedico Rizzoli
Bologna, Italy
Recruiting now
- Toni Ibrahim, MD(contact)ND [email protected]
A.O. Universitaria Meyer
Florence, Italy 50139
Recruiting now
- Angela Tamburini, MD(contact)+3905556 [email protected]
- Angela Tamburini, MD(principal investigator)
Istituto Giannina Gaslini
Genova, Italy
Recruiting now
- Carla Manzitti, MD(contact)ND [email protected]
- Carla Manzitti, MD(principal investigator)
FONDAZIONE IRCCS Istituto Nazionale dei Tumori
Milan, Italy
Recruiting now
- Rossella Bertulli, MD(contact)0039022390 [email protected]
- Rossella Bertulli, MD(principal investigator)
FONDAZIONE IRCCS Istituto Nazionale dei Tumori
Milan, Italy
Recruiting now
- Roberto Luksch, MD(contact)02.2390 [email protected]
- Roberto Luksch, MD(principal investigator)
Azienda Ospedaliera Santobono Pausilipon
Naples, Italy
Opening soon
- Massimo Eraldo Abate, MD(contact)nd [email protected]
Azienda Ospedaliera di Padova
Padova, Italy
Recruiting now
- Gianni Bisogno, MD(contact)039049-8211 [email protected]
- Gianni Bisogno, MD(principal investigator)
ARNAS P. O. "Civico e Benfratelli"
Palermo, Italy 90127
Recruiting now
- Paolo D'Angelo, MD(contact)039 091666 [email protected]
Azienda Ospedaliera Universitaria di Parma
Parma, Italy
Recruiting now
- Patrizia Bertolini, MD(contact)ND [email protected]
Azienda Ospedaliero-Universitaria Pisana
Pisa, Italy 56126
Recruiting now
- Luca Coccoli, MD(contact)0039050992 [email protected]
- Luca Coccoli, MD(principal investigator)
Ospedale Pediatrico Bambin Gesu'
Roma, Italy
Opening soon
- Giuseppe Maria Milano, MD(contact)06 68591 [email protected]
- Giuseppe Maria Milano, MD(principal investigator)
Istituto Regina Elena - IFO
Rome, Italy 00100
Recruiting now
- Virginia Ferraresi, MD(contact)+39065266919 [email protected]
Ospedale Infantile Regina Margherita - Unit of Paediatric Oncoematology
Torino, Italy 10126
Recruiting now
- Franca Fagioli, MD(contact)+39011313 [email protected]
- Franca Fagioli, MD(principal investigator)
IRCCS materno infantile Burlo Garofolo
Trieste, Italy 34137
Recruiting now
- Marco Rabusin, MD(contact)0403785 [email protected]
- Marco Rabusin, MD(principal investigator)

See the official eligibility language

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion Criteria:

1. Diagnosis of Ewing's sarcoma of the bone
2. Diagnosis of Ewing-like sarcoma (round cell sarcoma with fusion of the EWSR1 gene with others not of the ETS family, sarcoma with CIC rearrangement or sarcoma with BCOR rearrangement)
3. Diagnosis of extraosseous Ewing's sarcoma for patients
4. Age at diagnosis \<50 years
5. Assessment of the extent of the disease at onset in accordance with the European Society of Medical Oncology guidelines
6. Patients or parents oe guardians of minors who have given their written informed consent to participate in the study

Exclusion Criteria:

1\. Presence of comorbid factors who can compromise the compliance of the treatment plan or the evaluation of the outcomes, including but not limited to organ pathologies that contraindicate the use of chemotherapy and psychological or social conditions that do not allow for adequate compliance treatment or adequate follow-up

Updated 2026-01-02 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.